Business
Why the Noxopharm (ASX:NOX) share price is jumping 14% higher today
While the S&P/ASX 200 Index (ASX: XJO) is slipping today, the Australian clinical-stage drug developer Noxopharm Ltd (ASX: NOX) is bucking the trend with its shares rising.
At the time of writing, the Noxopharm share price is up 14.13% to 52 cents.
Why is the Noxopharm share price increasing?
Cancer drug update
Noxopharm released a shareholder update to the market this morning pertaining to its drugs in development.
In the update, Noxopharm states that its immunotherapy drug, Veyonda, is emerging as a major new treatment. The company goes on to describe the potential value as ‘multi-billion dollar’, based on its ability to boost the effectiveness of all 3 current methods of cancer treatment: immune-oncology therapy,…
-
Noosa News22 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News23 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business23 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News22 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots